A proven track record
More than 300 million people worldwide have used products developed from our research. Learn more.
We’re leading the way in developing new treatments for a broad range of viral respiratory infections. See how.
We also have our sights on chronic hepatitis B and other innovative new treatments for infectious diseases, cancers, nerve pain and neurodegenerative diseases. Learn more.